Eli Lilly starts human study of potential COVID-19 treatment

Deutschland Nachrichten Nachrichten

Eli Lilly starts human study of potential COVID-19 treatment
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 Reuters
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

Eli Lilly and Co said on Monday first set of patients have been dosed in an early-stage trial to test its potential treatment for COVID-19, in the world's first study of an antibody treatment against the disease.

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. Picture taken February 1, 2018. REUTERS/Vincent Kessler

Lilly is one of several healthcare companies looking to develop a treatment for COVID-19, which has no approved treatment or vaccine and has caused over 370,000 deaths worldwide. The experimental treatment, LY-CoV555, has been developed through collaboration with privately held AbCellera Biologics, which Lilly partnered with in March to test antibodies to treat and prevent COVID-19.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Reuters /  🏆 2. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

How Anxiety Shapes Extreme Social DistancingHow Anxiety Shapes Extreme Social DistancingWhy are some people vigilant about social distancing while others are more lax? It all comes down to psychology.
Weiterlesen »

South Korea's Celltrion aims to start in-human COVID-19 drug trial in JulySouth Korea's Celltrion aims to start in-human COVID-19 drug trial in JulySouth Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated an up to 100-fold reduction in viral load of the disease in animal testing, saying it aims to start in-human clinical trials in late July.
Weiterlesen »

South Korea's Celltrion says COVID-19 drug shows drop in viral load in animal testingSouth Korea's Celltrion says COVID-19 drug shows drop in viral load in animal testingSouth Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated a 100-fold reduction in viral load of the disease in animal testing.
Weiterlesen »

Rwandan medical workers deploy robots to minimize coronavirus riskRwandan medical workers deploy robots to minimize coronavirus riskAt the Kanyinya COVID-19 treatment facility a short distance from Rwanda's capital Kigali, Akazuba, Ikizere and Ngabo report for duty, but these are no ordinary health care workers.
Weiterlesen »

The ’Non Essential’ Business Owners Who Went UndergroundThe ’Non Essential’ Business Owners Who Went UndergroundMany small businesses in Los Angeles refused to close after the county's mid-March “Safer at Home“ order. What it’s like to run a shadow business in the era of Covid-19:
Weiterlesen »

Veterinarian, a COVID-19 survivor, on trying to care for pets, her staff and herselfVeterinarian, a COVID-19 survivor, on trying to care for pets, her staff and herselfVeterinarian, a COVID-19 survivor, on trying to care for pets, her staff and herself.
Weiterlesen »



Render Time: 2025-03-31 21:38:14